News | Medicines Discovery Catapult

We can arrange media interviews and tours of our laboratory and facilities. Spokespeople, including our CEO, Chris Molloy, are available to comment on our unique approach to supporting SMEs and the discovery of new medicines.

We can also provide expert opinion and analysis on the UK government’s Industrial Strategy, the role of the NHS, SMEs, pharma and the importance of patient data in drug discovery. You can find out more about our work in the State of the Discovery Nation report.

For more information please email media@md.catapult.org.uk.

Signup to our media list to be kept up-to-date with our work and commentary and opinion on key news stories.

Investigating new treatment for schizophrenia as first Psychiatry Consortium funded project announced

A partnership between the University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia. This is the first project to be funded by the international Psychiatry Consortium, a £4 million collaboration between seven global pharmaceutical […]

Testing Lab Data Reveals Spread of New Covid Variant Across the Country

Scientists at the Alderley Park Lighthouse Lab in Cheshire have revealed the speed and scale at which the new variant of the COVID virus is spreading through communities across the country. The Lighthouse, operated by Medicines Discovery Catapult (MDC) and launched last April, plays a key role in the UK Government’s national COVID testing […]

Alderley Park Lighthouse Lab Processes 6 Millionth Sample

Scientists at the Alderley Park Lighthouse Lab in Cheshire processed their 6 millionth test over the festive period, the equivalent of providing tests for one in ten people in the UK. The facility, operated by Medicines Discovery Catapult (MDC) and launched last April, plays a key role in the UK Government’s national COVID testing programme […]

Cheshire’s COVID Christmas Champions

Shining a spotlight on the region’s scientists who will be working throughout the festive period The vast majority of us will be looking forward to a well-deserved break over Christmas and New Year; kicking back, relaxing and saying a fond farewell to what has undoubtedly been a tumultuous 2020. With an extended Christmas break this […]

UK Innovators Target Nanoparticles at Inoperable Cancers

Active Needle Technology, Xerion Healthcare and Medicines Discovery Catapult win funding to begin ground-breaking project At a point of critical clinical need for improved treatments for pancreatic and head and neck cancers, a partnership of healthcare innovators set out to revolutionise radiotherapy for inoperable, and the most difficult to treat tumours. With the aim of […]

Biology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow

Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment Medicines discovery innovators, Intelligent OMICS, supported by Arctoris and Medicines Discovery Catapult, are applying artificial intelligence to find new disease ‘drivers’ and candidate drugs for lung cancer. This collaboration, backed by Innovate UK, will de-risk future R&D […]

Innovate UK Funded Project Produces Next-Generation AI Drug Discovery Platform

Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research The consortium behind the DeepADMET project set up to advance artificial intelligence (AI) technologies for drug discovery, today announced the successful conclusion of this project which was funded by Innovate UK, the UK’s innovation agency. Optibrium – a developer of […]

UK innovation and technology centres highlight track record for delivering business growth

The Catapult Network launched today the 2019-2020 Annual Report – Creating the future through innovation: Recovery and Resilience. As an economic emergency grips a nation reeling from a health crisis, our society is concerned with how the UK emerges from the pandemic with a strong economy, one that continues to enable opportunities for business growth, […]

Covid testing pioneer named as a BioBusiness Mover and Shaker

Dr Sally Price, Head of Cell and Translational Science at Medicines Discovery Catapult (MDC) has been named in BioBeat’20 Movers & Shakers in BioBusiness 2020. Dr Price was instrumental in setting up the Alderley Park Lighthouse Lab, which forms part of the largest diagnostic testing facility in British history, to help in the fight against […]

Older posts

Newer posts